Cargando…
Cinacalcet in HIV haemodialysis patients
Autores principales: | Belmouaz, Simohamed, Bauwens, Marc, Chauvet, Sophie, Bridoux, Frank, Touchard, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421257/ https://www.ncbi.nlm.nih.gov/pubmed/25983947 http://dx.doi.org/10.1093/ndtplus/sfn056 |
Ejemplares similares
-
Protein loss and medium cut-off haemodialysis
por: Belmouaz, Mohamed, et al.
Publicado: (2019) -
Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?
por: Rottembourg, Jacques, et al.
Publicado: (2018) -
The administration of cinacalcet hydrochloride just before a haemodialysis session suppresses the transient rise in intact parathyroid hormone induced by a low-calcium dialysate: when should cinacalcet hydrochloride be administered?
por: Date, Toshiyuki, et al.
Publicado: (2008) -
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes
por: Louie, Karly S., et al.
Publicado: (2019) -
Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)